Form 10-K/A Forte Biosciences, Inc. For: Dec 31
Forte Biosciences, Inc. (FBRX)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
FBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FBRX alerts
High impacting Forte Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
FBRX
News
- Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesBusiness Wire
- Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business UpdateBusiness Wire
- Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant [Yahoo! Finance]Yahoo! Finance
- Forte Biosciences, Inc. (NASDAQ: FBRX) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.75 price target on the stock.MarketBeat
- Forte Biosciences, Inc. Announces 2023 Results and Provides Business UpdateBusiness Wire
FBRX
Analyst Actions
- 4/8/24 - Ladenburg Thalmann
FBRX
Sec Filings
- 5/13/24 - Form 10-Q
- 5/13/24 - Form 8-K
- 4/12/24 - Form S-8
- FBRX's page on the SEC website